A Deliberate Distinction from Other Networks
In an interview with Deutschlandfunk, Prof. Dr. Anna Zeiter, co-founder of W Social and professor of European data law at the University of Bern, highlights the key differences from existing networks:
‍
Core Concepts and Technical Differentiation
In an interview with Deutschlandfunk, Prof. Dr. Anna Zeiter, co-founder of W Social and professor of European data law at the University of Bern, highlights the key differences from existing networks:
- Human verification: To address the issue of AI bots and targeted disinformation, users must verify once that they are real people (e.g., by verifying their ID). According to Zeiter, the biometric data is deleted immediately after verification; only an encrypted token remains to confirm the user’s identity.
- European Hosting: Unlike U.S. platforms, the data is hosted by a Finnish provider, meaning it is hosted in Europe. In addition, the shareholder agreement ensures that European shareholders hold a majority of the voting rights in the company.
- Interoperability: W Social uses the AT Protocol (as do BlueSky and Eurosky), which enables communication across platforms with approximately 40 million existing users.
- Private Funding: The platform is funded entirely by private investors, primarily from the Scandinavian ecosystem as well as from Germany, Belgium, and Switzerland.
Potential Relevance for the Pharmaceutical and Healthcare Industries
Pharmaceutical companies can use the platform to communicate in a validated environment that is less susceptible to populist distortions. W Social’s approaches could indeed bridge a gap that U.S. platforms have so far failed to address:
- ‍Validity Instead of Anonymity
‍Human verification lowers the barrier for companies to engage in direct dialogue, as it drastically reduces the risk of bot-driven “backlash” or targeted disinformation.‍ - Combating Fake News
‍Inhealth communication, the validity of information is very important. Zeiter emphasizes that verification by real people is intended to curb much of the misinformation that is often driven by AI bots. This could provide a safer space for expert medical discussions.‍ - Legal Certainty Through Data Sovereignty
‍Sincethe platform is based on European data law and the data is also hosted within the EU, it provides a regulatory framework that aligns better with the pharmaceutical industry’s strict compliance requirements than the often opaque algorithms from Silicon Valley.‍ - Transparency Requirements for Companies
‍Therequirement to name a specific person responsible for company profiles reinforces the credibility of statements. At a time when AI-generated content is on the rise, this “human touch” is becoming a hallmark of quality.
Synergy in Pharmaceutical Communication
The combination of verified doctors, real patients, and transparent pharmaceutical companies (with profiles that identify the individuals responsible) could make W Social the first “high-trust” network for healthcare .
The launch of W Social marks far more than just an attempt to establish a European alternative to X. In a market environment strictly regulated by the German Law on the Advertising of Medicines (HWG) and the GDPR, the platform offers a safe space for the first time—precisely because of its mandatory human verification. For pharmaceutical companies, this could mean an end to uncontrollable bot interactions, which have often been the biggest obstacle to direct stakeholder dialogue.
And here’s another point: Just as dependence on foreign drug supply chains jeopardizes physical health care, dependence on opaque algorithms controlled by the U.S. or China threatens the reliable flow of information. By establishing different framework conditions, the platform can safeguard the “information supply chain.”
A potential strategic safeguard for pharmaceutical companies: In the event of geopolitical tensions or digital disinformation campaigns, a validated communication channel remains in place that cannot be shut down by external actors or manipulated by bot networks. A strategic tool for sustainably regaining scientific authority in a validated, bot-free environment.
